News

Eli Lilly and Company and Asahi Kasei Pharma Corporation announced a license agreement whereby Lilly will acquire the exclusive rights for AK1780 from Asahi Kasei Pharma. AK1780 is an…
Read More...

Hoth Therapeutics, Inc. announced extending a research collaboration agreement with Weill Cornell Medicine to continue investigating the therapeutic mechanism of action and safety of…
Read More...

Sanofi and BioNTech have entered into an agreement under which Sanofi will support manufacturing and supply of BioNTech’s COVID-19 vaccine which is being co-developed with Pfizer.…
Read More...

Cognate BioServices, Inc., the premier commercial-ready global CDMO in the Cell and Gene Therapy industry, and Nucleus Biologics, LLC, The Cell Performance Company, announced a…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines confirmed that the Company is in discussion with the U.S. government to purchase an…
Read More...

Ajinomoto Bio-Pharma Services  and Humanigen announced the companies will be expanding their manufacturing agreement for the fill finish supply of lenzilumab, which is one of the few…
Read More...

Eli Lilly and Company, Vir Biotechnology, Inc. and GlaxoSmithKline plc announced a collaboration to evaluate a combination of two COVID-19 therapies in low-risk patients with mild to…
Read More...

Care Access Research, a decentralized research organization (DRO) that operates as one connected team of physicians and research experts, announced a collaboration with global…
Read More...

Agenus Inc. an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and…
Read More...

AstraZeneca’s Symbicort Turbuhaler (budesonide/formoterol 160/4.5mcg) has been approved in China as an anti-inflammatory reliever to be taken as-needed in response to symptoms to…
Read More...

Mundipharma and Cidara Therapeutics  announced that the European Commission (EC) has now adopted the European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products (COMP)…
Read More...

Merck, known as MSD outside the United States and Canada, announced that the company is discontinuing development of its SARS-CoV-2/COVID-19 vaccine candidates, V590 and V591, and plans…
Read More...

Humanetics Corporation (Humanetics) announced that it has received funding from the U.S. Department of Defense to conduct a series of studies with its new drug candidate, BIO 300. BIO…
Read More...

Evozyne, LLC, a privately held molecular engineering technology company founded by life science innovator Paragon Biosciences, announced the signing of a strategic collaboration and…
Read More...

Moderna Inc. announced results from in vitro neutralization studies of sera from individuals vaccinated with Moderna COVID-19 Vaccine showing activity against emerging strains of…
Read More...

BioNTech SE and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. announced that according to the Food and Health Bureau of the Hong Kong Special Administrative Region of the PRC ("Hong…
Read More...

Eli Lilly and Company  announced the successful completion of its acquisition of Prevail Therapeutics Inc. The acquisition establishes a new modality for drug discovery and development…
Read More...

Elasmogen Ltd, the pioneering biopharmaceutical company leading the development of VNAR and soloMER™ biologics, announces a significant breakthrough in the identification of…
Read More...

Turn Therapeutics, a biotechnology company specializing in advanced wound care and infection control, announced the initiation of a two-part, four-arm, human safety and efficacy trial…
Read More...

Servier, a global and independent pharmaceutical Group, and MiNA Therapeutics, the pioneer in RNA activation therapeutics, announced a research partnership to identify and develop small…
Read More...